Intrivo Learn More Accessible, Reliable, and Sophisticated
In Vitro Diagnostics
More Info CARESTART™ POWERED BY ACCESS BIO Covid-19 Rapid Antigen US-made intended point-of-care (POC) test with results in minutes More Info INTRIVO NEWS Stay up to date with our news and updates

CareStart™ Products


Our full range of COVID-19 testing solutions enables testing in different settings to fulfill the diagnostic needs of healthcare providers and patients. The COVID-19 antigen test and our molecular test (MDx RT-PCR) help detect acute or persistent infection, while our serology test (COVID-19 IgM/IgG) helps detect antibodies that show recent or past infection.

CareStart™ COVID-19 Antigen Test


CareStart PCR test

CareStart™ COVID-19
MDx RT-PCR Test

CareStart Antigen test

CareStart™ COVID-19
Antigen Test

CareStart Antibody test

CareStart™ COVID-19
IgM/IgG Test

CareStart Antigen

The CareStart™ Covid-19 Antigen test is affordable, consistent, and easy-to-use, with results in 10 minutes. CareStart™ Antigen is now approved for use with lower nasal swabs (anterior nares). To accommodate the tremendous demand of this test, Intrivo is continuing to quickly expand our production capacity.

All available CareStart™ COVID-19 tests have received Emergency Use Authorization (EUA) by the FDA.

Intrivo:
Where Innovation Meets Purpose


As a digital health company, our mission is to combine intuitive tools with comprehensive health information to steward patients from triage to recovery and sustained wellness. Serving as the exclusive US commercialization partner for access bio, we are providing sophisticated, accessible, and accurate testing solutions for COVID-19 to fit your organization’s needs.

Stay up to date with CareStart™ News and Events

Stay up to date with CareStart™ News and Events

We are here to answer any questions you may have





    Meet our authorized distributors